North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.310

-7.1%

12:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mama Bear who wrote (397)	7/31/1998 7:30:00 AM
From: andy harrison	Read Replies (1) of 507

Barb: Sturza (the short leader) first started shorting NVX back in the 1993 -1994 time frame when the stock was 8.13. If you look at old Sturza model portfolios who will see that his cost basis was 8.13. He has raised his cost basis on current portfolios because he has recommended shorting more at the higher 20's level. The story is this..the stock was in the 8's and he attacked. He had Dorfman pan NVX 3 times on CNBC and the short interest swelled to 2.9-3 million shares.. (That is a fact). The stock was driven down to 5 3/4 and then rose from there. The short interest has NEVER been lower than 2.9 million and was a high as 4.2 million and IMO, it will be closing in on 4.5 million at the close of the july-august period. For some reason, they think that they can crack the longs but for nearly 4 years the truth of what NVX has in potential has proved a stronger factor than his half a page of periodic prose. Research the facts; get the annual report; and then decide. This is a fine company that if not taken over in the not to distant future will have incredible revenues from their product pipeline and reward shareholders.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next